QuidelOrtho's digital transformation strategy involves integrating advanced diagnostic technologies with robust IT infrastructure. The company focuses on expanding molecular diagnostics, automating laboratory workflows, and enhancing cloud capabilities for rapid product deployment. This approach prioritizes innovation in diagnostic platforms and operational efficiency across its global footprint.
This transformation creates dependencies on seamless system integrations, reliable data pipelines, and stringent governance protocols. Complexities arise in unifying diverse diagnostic platforms and ensuring consistent data flow between laboratory systems and external healthcare IT. This page analyzes QuidelOrtho's initiatives, associated challenges, and opportunities for external partners.
QuidelOrtho Snapshot
Headquarters: San Diego, USA
Number of employees: 6,500
Public or private: Public
Business model: B2B & B2C
Website: https://www.quidelortho.com/
QuidelOrtho ICP and Buying Roles
- QuidelOrtho sells to healthcare organizations with complex diagnostic testing needs, including large hospital systems, reference laboratories, and point-of-care settings.
Who drives buying decisions
- Chief Medical Officer → Oversees clinical strategy and diagnostic accuracy requirements
- Head of Laboratory Operations → Manages laboratory efficiency and system integration
- Chief Information Officer → Directs IT infrastructure, cloud adoption, and data security
- VP of Supply Chain → Manages inventory, logistics, and distribution network resilience
Key Digital Transformation Initiatives at QuidelOrtho (At a Glance)
- Expanding molecular diagnostic portfolio with new assay development
- Integrating rapid molecular testing capabilities through strategic acquisitions
- Implementing laboratory automation solutions with VITROS Systems
- Establishing a Cloud Business Office for AWS service governance
- Connecting diagnostic instruments with Laboratory Information Systems (LIS) and Electronic Medical Records (EMR)
- Launching a new informatics solution, QuidelOrtho Results Manager System
- Optimizing global supply chain and distribution network management
Where QuidelOrtho’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Integration Platforms | Molecular diagnostics expansion: data exchange between acquired LEX Diagnostics platform and existing LIS fails. | VP of R&D, Head of IT | Consolidate data from disparate diagnostic platforms into a unified system. |
| LIS/EMR/Middleware connectivity: HL7 interfaces transmit incomplete patient test results to LIS. | Head of Laboratory Operations, Chief Medical Officer | Validate data formats and completeness before LIS transmission. | |
| LIS/EMR/Middleware connectivity: order data from EMR systems fails to sync with diagnostic analyzers. | Head of Laboratory Operations, Chief Medical Officer | Enforce bidirectional order and result communication protocols. | |
| Data Governance & Observability | Cloud Business Office establishment: inconsistent data appears in cloud resource utilization reports. | Chief Information Officer, Head of Cloud Operations | Standardize cloud resource tagging and cost allocation metrics. |
| Results Manager System deployment: quality control data from instruments does not centralize for real-time monitoring. | Head of Laboratory Operations, Quality Assurance Manager | Aggregate quality control data from all connected instruments. | |
| Workflow Automation Solutions | Laboratory automation with VITROS Systems: automated aliquoting stations occasionally mislabel samples. | Head of Laboratory Operations | Detect and correct sample mislabeling during automated processing. |
| Laboratory automation with VITROS Systems: manual validation is required for specific test result releases. | Head of Laboratory Operations | Automatically verify routine test results based on predefined rules. | |
| Supply Chain & Logistics | Supply chain optimization: inventory data across new distribution centers does not reconcile with ERP stock levels. | VP of Supply Chain | Reconcile inventory discrepancies between disparate warehouse management systems and ERP. |
| AI/ML for Diagnostics | Molecular diagnostics expansion: new assay development generates false positives in early clinical validations. | VP of R&D, Chief Medical Officer | Validate AI model outputs against established clinical benchmarks before deployment. |
Identify when companies like QuidelOrtho are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this QuidelOrtho’s digital transformation unique
QuidelOrtho’s digital transformation centers on integrating diverse diagnostic technologies, from point-of-care rapid tests to high-throughput laboratory systems, following a significant merger. This approach heavily depends on robust LIS/EMR connectivity and data management platforms to unify information across varied clinical settings. Their strategy is distinct in balancing rapid innovation, such as the LEX Diagnostics acquisition, with the need for standardized and automated lab operations globally.
QuidelOrtho’s Digital Transformation: Operational Breakdown
DT Initiative 1: Expanding Molecular Diagnostic Portfolio
What the company is doing
QuidelOrtho is actively developing and launching new molecular diagnostic assays for various conditions like STIs and GI panels. The company also acquires advanced molecular testing technologies, such as the LEX Diagnostics ultra-fast thermal cycling platform. This expands their product offerings and market presence in molecular diagnostics.
Who owns this
- VP of R&D
- Chief Medical Officer
Where It Fails
- New assay development workflows produce inconsistent results during validation testing.
- Integration of acquired molecular diagnostic platforms creates data format mismatches for reporting.
- Molecular test result data fails to transfer accurately to specific LIS systems.
- Validation data from new assays does not synchronize across internal R&D databases.
Talk track
Noticed QuidelOrtho is expanding its molecular diagnostic portfolio and integrating new technologies. Been looking at how some diagnostic companies are standardizing data from diverse platforms before integrating them into core systems, can share what’s working if useful.
DT Initiative 2: Laboratory Automation with VITROS Systems
What the company is doing
QuidelOrtho implements VITROS Automation Solutions across laboratories to streamline testing processes. These solutions include automated aliquoting, sample loading, and quality control functions. This helps manage high testing volumes and reduces manual intervention in lab operations.
Who owns this
- Head of Laboratory Operations
- VP of Manufacturing
Where It Fails
- Automated aliquoting systems misplace samples during high-volume processing.
- Automated capping mechanisms fail to secure sample tubes before storage.
- Automated result verification rules trigger false exceptions for standard tests.
- Sample tracking data does not update consistently across automated modules.
Talk track
Saw QuidelOrtho is implementing VITROS Automation Solutions in labs. Been looking at how some diagnostic labs prevent sample misplacement in automated workflows instead of manual re-sorting, happy to share what we’re seeing.
DT Initiative 3: Cloud Business Office and AWS Cloud Adoption
What the company is doing
QuidelOrtho established a Cloud Business Office (CBO) to govern its cloud strategy and manage AWS service consumption. They leverage AWS for developing and deploying new products and services, including IoT solutions that consolidate data from testing devices. This supports agile development and cloud migration of applications.
Who owns this
- Chief Information Officer
- Head of Cloud Operations
Where It Fails
- Cloud resource allocation processes create unexpected cost overruns in development environments.
- IoT data streams from diagnostic devices fail to consolidate into central cloud repositories.
- Security configurations for new cloud deployments do not align with established governance policies.
- Data access controls in cloud storage systems do not enforce role-based permissions consistently.
Talk track
Looks like QuidelOrtho is scaling its AWS cloud adoption and established a Cloud Business Office. Been seeing teams enforce cloud cost policies automatically instead of manual reconciliation, can share what’s working if useful.
DT Initiative 4: LIS/EMR/Middleware Connectivity and Data Management
What the company is doing
QuidelOrtho integrates its diagnostic analyzers with Laboratory Information Systems (LIS) and Electronic Medical Record (EMR) systems. They use standard interfaces like HL7 for automated data exchange, including patient test results and orders. The company also provides data management systems such as QuidelOrtho Results Manager to centralize data and monitor quality across instruments.
Who owns this
- Head of IT
- Head of Laboratory Operations
- Chief Medical Officer
Where It Fails
- Patient demographics from EMR systems do not accurately transfer to diagnostic instrument orders.
- Test results from point-of-care devices fail to upload automatically to the central LIS.
- Quality control data from different instrument platforms does not centralize into the Results Manager system.
- Middleware platforms create duplicate test entries in the LIS during peak hours.
Talk track
Noticed QuidelOrtho emphasizes LIS/EMR connectivity for its diagnostic platforms. Been looking at how some healthcare providers validate patient data before it enters diagnostic workflows, happy to share what we’re seeing.
Who Should Target QuidelOrtho Right Now
This account is relevant for:
- Diagnostic Integration and Interoperability Platforms
- Laboratory Automation and Robotics Providers
- Cloud Governance and Cost Optimization Solutions
- Data Observability and Quality Platforms for Healthcare
- Supply Chain and Logistics Optimization Software
- AI/ML Model Validation and Explainability Tools
Not a fit for:
- Basic website builders with no integration capabilities
- Standalone marketing tools without system connectivity
- Generic IT helpdesk solutions
- Consumer-facing wellness apps
When QuidelOrtho Is Worth Prioritizing
Prioritize if:
- You sell platforms that validate data integrity between disparate molecular diagnostic systems.
- You sell solutions that prevent sample mislabeling in automated laboratory workflows.
- You sell tools that enforce cloud resource policies to prevent cost overruns.
- You sell systems that ensure accurate patient demographic transfer between EMR and diagnostic orders.
- You sell platforms that unify inventory data across multiple distribution centers.
- You sell AI model validation tools that prevent false positives in diagnostic assay development.
Deprioritize if:
- Your solution does not address any of the breakdowns above.
- Your product is limited to basic functionality with no integration capabilities.
- Your offering is not built for multi-team or multi-system environments in a regulated industry.
Who Can Sell to QuidelOrtho Right Now
Diagnostic Integration Platforms
Rhapsody (Orion Health) - This company offers an interoperability platform that facilitates secure and reliable exchange of healthcare data.
Why they are relevant: Integration of acquired molecular diagnostic platforms creates data format mismatches for reporting. Rhapsody can standardize data formats and ensure seamless data flow between QuidelOrtho's diverse diagnostic systems and external LIS/EMR platforms.
Corepoint Health (now Lyniate) - This company provides an enterprise-grade integration engine specifically designed for healthcare.
Why they are relevant: Test results from point-of-care devices fail to upload automatically to the central LIS. Corepoint Health can establish robust, automated interfaces to ensure reliable transmission of results from all diagnostic instruments to the LIS.
Laboratory Automation Software
Data Innovations - This company offers laboratory middleware solutions that connect instruments and manage data.
Why they are relevant: Automated result verification rules trigger false exceptions for standard tests. Data Innovations can configure complex rules engines to automatically verify routine test results, reducing manual review and improving workflow efficiency.
Beckman Coulter - This company provides automated laboratory systems and workflow solutions.
Why they are relevant: Automated aliquoting systems misplace samples during high-volume processing. Beckman Coulter can implement advanced robotic systems with enhanced sample identification and tracking to prevent misplacement in automated workflows.
Cloud Governance and Management Solutions
CloudHealth by VMware - This company provides a multi-cloud management platform for cost, security, and compliance.
Why they are relevant: Cloud resource allocation processes create unexpected cost overruns in development environments. CloudHealth can provide granular visibility into AWS spending and enforce budget policies across QuidelOrtho's cloud infrastructure.
Dome9 (Check Point Software) - This company offers cloud security and compliance automation for public clouds.
Why they are relevant: Security configurations for new cloud deployments do not align with established governance policies. Dome9 can automate security policy enforcement and compliance checks across QuidelOrtho's AWS environment, ensuring adherence to regulatory standards.
Data Quality and Observability for Healthcare
Datadog - This company provides a monitoring and analytics platform for cloud applications and infrastructure.
Why they are relevant: Quality control data from different instrument platforms does not centralize into the Results Manager system. Datadog can collect and aggregate quality control data from all connected diagnostic instruments for real-time monitoring and anomaly detection.
Informatica - This company offers enterprise cloud data management solutions.
Why they are relevant: Middleware platforms create duplicate test entries in the LIS during peak hours. Informatica can detect and eliminate duplicate test entries before they are committed to the LIS, ensuring data accuracy and system integrity.
Final Take
QuidelOrtho is actively scaling its diagnostic product portfolio and automating laboratory operations. Breakdowns are visible in data integration between diverse platforms, cloud resource governance, and automated workflow reliability. This account is a strong fit for solutions that enforce data consistency, automate complex validation steps, and ensure robust interoperability across their expanding diagnostic ecosystem.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.